Norihiro Furusyo Selected Research

telaprevir

12/2015	Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
11/2015	Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C.
8/2015	Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C.
4/2015	Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.
1/2015	Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.
1/2015	Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection.
9/2014	Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.
9/2014	A case of successful treatment with telaprevir-based triple therapy for hepatitis C infection after treatment failure with vaniprevir-based triple therapy.
5/2014	A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
4/2014	Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norihiro Furusyo Research Topics

Disease

47	Chronic Hepatitis C 10/2022 - 12/2003
47	Infections 02/2022 - 08/2002
19	Fibrosis (Cirrhosis) 10/2023 - 01/2006
16	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2003
14	Chronic Hepatitis B 10/2023 - 01/2005
11	Hepatitis C 12/2021 - 12/2003
10	Atherosclerosis 12/2021 - 07/2003
9	Carotid Artery Diseases 09/2018 - 07/2003
9	Viremia 06/2013 - 03/2002
8	HIV Infections (HIV Infection) 01/2017 - 12/2002
8	Anemia 12/2016 - 11/2012
7	Hypertension (High Blood Pressure) 12/2020 - 02/2004
7	Atopic Dermatitis (Atopic Eczema) 08/2019 - 04/2005
6	Liver Diseases (Liver Disease) 05/2014 - 01/2006
5	Chronic Renal Insufficiency 10/2023 - 02/2015
5	Diabetes Mellitus 01/2020 - 07/2003
5	Insulin Resistance 03/2017 - 12/2007
4	Virus Diseases (Viral Diseases) 01/2017 - 12/2007
4	Immune Reconstitution Inflammatory Syndrome 01/2017 - 07/2008
4	Thrombocytopenia (Thrombopenia) 02/2015 - 02/2012
3	Hepatitis 04/2022 - 05/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 02/2012
3	Coinfection 01/2018 - 11/2012
3	Hepatitis B 01/2018 - 04/2015
3	Exanthema (Rash) 01/2018 - 12/2015
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2011 - 07/2008
2	Glucose Intolerance 12/2021 - 01/2014
2	Osteoporosis 01/2021 - 06/2013
2	Arthritis (Polyarthritis) 01/2019 - 10/2008
2	Hypertriglyceridemia 03/2018 - 02/2012
2	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2015
2	Inflammation (Inflammations) 01/2017 - 02/2012
2	Food Hypersensitivity (Food Allergy) 11/2016 - 09/2008
2	Asthma (Bronchial Asthma) 04/2015 - 09/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 05/2007

Drug/Important Bio-Agent (IBA)

33	InterferonsIBA 02/2022 - 03/2002
28	Ribavirin (Virazole)FDA LinkGeneric 06/2019 - 07/2005
25	Antiviral Agents (Antivirals)IBA 10/2022 - 04/2010
14	telaprevirIBA 12/2015 - 08/2013
13	RNA (Ribonucleic Acid)IBA 12/2020 - 03/2002
8	Tenofovir (Viread)FDA Link 04/2022 - 05/2014
8	AlbuminsIBA 12/2021 - 07/2003
8	Alanine Transaminase (SGPT)IBA 12/2020 - 08/2002
8	SofosbuvirIBA 09/2020 - 12/2016
6	tenofovir alafenamideIBA 10/2023 - 01/2017
6	entecavir FDA Link 10/2023 - 06/2015
6	Triglycerides (Triacylglycerol)IBA 08/2023 - 10/2010
6	oxidized low density lipoproteinIBA 10/2020 - 02/2012
5	LDL CholesterolIBA 12/2021 - 02/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2006
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 08/2004
5	C-Reactive ProteinIBA 01/2019 - 09/2002
5	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 10/2010
5	Lamivudine (Epivir)FDA Link 06/2015 - 01/2005
5	Proteins (Proteins, Gene)FDA Link 10/2014 - 07/2007
5	Interferon-alpha (Interferon Alfa)IBA 04/2006 - 12/2003
4	CholesterolIBA 08/2023 - 08/2006
4	HDL CholesterolIBA 12/2021 - 02/2004
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2013
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 09/2013
4	AntigensIBA 08/2019 - 10/2005
4	Hemoglobins (Hemoglobin)IBA 12/2016 - 10/2013
4	Immunoglobulin E (IgE)IBA 11/2016 - 04/2005
4	Hepatitis B e AntigensIBA 04/2015 - 08/2002
3	adefovir dipivoxil (Hepsera)FDA Link 10/2023 - 02/2015
3	Chemokine CCL17IBA 08/2019 - 09/2007
3	asunaprevirIBA 06/2019 - 03/2017
3	daclatasvirIBA 06/2019 - 03/2017
3	EndostatinsIBA 09/2018 - 06/2016
3	SimeprevirIBA 03/2017 - 08/2015
3	Serum AlbuminIBA 01/2015 - 05/2007
3	Immunoglobulin A (IgA)IBA 09/2009 - 08/2002
2	LipidsIBA 08/2023 - 08/2006
2	Fetal Proteins (Fetoprotein)IBA 10/2022 - 01/2020
2	Inositol (Myoinositol)IBA 12/2021 - 01/2014
2	InterleukinsIBA 12/2021 - 09/2012
2	BilirubinIBA 12/2020 - 06/2013
2	AdiponectinIBA 10/2020 - 12/2007
2	sofosbuvir drug combination ledipasvirIBA 02/2020 - 06/2019
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 04/2015
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2018 - 01/2006
2	ProdrugsIBA 01/2018 - 01/2017
2	Insulin (Novolin)FDA Link 03/2017 - 11/2016
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2017 - 05/2014
2	Inosine Triphosphate (ITP)IBA 12/2016 - 03/2013
2	NucleotidesIBA 12/2016 - 06/2015
2	PyrophosphatasesIBA 12/2016 - 03/2013
2	LigandsIBA 11/2016 - 01/2013
2	ChemokinesIBA 11/2016 - 09/2007
2	Interferon-betaIBA 03/2016 - 12/2003
2	adefovirIBA 02/2015 - 06/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 09/2007

Therapy/Procedure

34	Therapeutics 01/2020 - 07/2005
6	Renal Dialysis (Hemodialysis) 06/2019 - 09/2002
6	Highly Active Antiretroviral Therapy (HAART) 01/2011 - 12/2002
5	Art Therapy 01/2017 - 11/2012
4	Liver Transplantation 01/2019 - 03/2013
3	Drug Tapering 01/2018 - 03/2013
3	Splenectomy 09/2014 - 02/2012
2	Aftercare (After-Treatment) 09/2020 - 09/2014